By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a



Company News
Synergy Pharma To Present At The Leerink Partners Global Healthcare Conference 2/2/2016 11:38:52 AM
Synergy Pharma Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation 2/1/2016 11:22:38 AM
Synergy Pharma Announces Positive Trial Results With Dolcanatide In Patients With Ulcerative Colitis, Confirming The Role Of Uroguanylin In Inflammatory Bowel Disease 1/11/2016 12:31:14 PM
Synergy Pharma Appoints Gary Sender As Chief Financial Officer 11/16/2015 11:16:35 AM
Synergy Pharma To Present At The Morgan Stanley Global Healthcare Conference 9/9/2015 10:48:17 AM
Synergy Pharma Reports Second Quarter And First Half 2015 Financial Results And Business Update 8/11/2015 11:08:42 AM
Synergy Pharma To Present At The Canaccord Genuity Growth Conference 8/4/2015 10:33:39 AM
Synergy Pharma Announces Positive Results In The Second Phase III Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation (CIC) 7/30/2015 6:31:33 AM
Synergy Pharma Appoints Troy Hamilton As Chief Commercial Officer 7/8/2015 10:41:54 AM
Synergy Pharma To Present At The Cantor Fitzgerald Healthcare Conference 6/30/2015 11:13:44 AM